150 related articles for article (PubMed ID: 10497246)
1. Enhanced expression, native purification, and characterization of CCR5, a principal HIV-1 coreceptor.
Mirzabekov T; Bannert N; Farzan M; Hofmann W; Kolchinsky P; Wu L; Wyatt R; Sodroski J
J Biol Chem; 1999 Oct; 274(40):28745-50. PubMed ID: 10497246
[TBL] [Abstract][Full Text] [Related]
2. A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1.
Siciliano SJ; Kuhmann SE; Weng Y; Madani N; Springer MS; Lineberger JE; Danzeisen R; Miller MD; Kavanaugh MP; DeMartino JA; Kabat D
J Biol Chem; 1999 Jan; 274(4):1905-13. PubMed ID: 9890944
[TBL] [Abstract][Full Text] [Related]
3. Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5.
Olson WC; Rabut GE; Nagashima KA; Tran DN; Anselma DJ; Monard SP; Segal JP; Thompson DA; Kajumo F; Guo Y; Moore JP; Maddon PJ; Dragic T
J Virol; 1999 May; 73(5):4145-55. PubMed ID: 10196311
[TBL] [Abstract][Full Text] [Related]
4. Paramagnetic proteoliposomes containing a pure, native, and oriented seven-transmembrane segment protein, CCR5.
Mirzabekov T; Kontos H; Farzan M; Marasco W; Sodroski J
Nat Biotechnol; 2000 Jun; 18(6):649-54. PubMed ID: 10835604
[TBL] [Abstract][Full Text] [Related]
5. Role of V3 independent domains on a dualtropic human immunodeficiency virus type 1 (HIV-1) envelope gp120 in CCR5 coreceptor utilization and viral infectivity.
Foda M; Harada S; Maeda Y
Microbiol Immunol; 2001; 45(7):521-30. PubMed ID: 11529558
[TBL] [Abstract][Full Text] [Related]
6. Human chemokine receptors CCR5, CCR3 and CCR2B share common polarity motif in the first extracellular loop with other human G-protein coupled receptors implications for HIV-1 coreceptor function.
Efremov R; Truong MJ; Darcissac EC; Zeng J; Grau O; Vergoten G; Debard C; Capron A; Bahr GM
Eur J Biochem; 1999 Aug; 263(3):746-56. PubMed ID: 10469138
[TBL] [Abstract][Full Text] [Related]
7. Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry.
Dragic T; Trkola A; Lin SW; Nagashima KA; Kajumo F; Zhao L; Olson WC; Wu L; Mackay CR; Allaway GP; Sakmar TP; Moore JP; Maddon PJ
J Virol; 1998 Jan; 72(1):279-85. PubMed ID: 9420225
[TBL] [Abstract][Full Text] [Related]
8. gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors.
Catani MV; Corasaniti MT; Navarra M; Nisticò G; Finazzi-Agrò A; Melino G
J Neurochem; 2000 Jun; 74(6):2373-9. PubMed ID: 10820198
[TBL] [Abstract][Full Text] [Related]
9. Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate.
Martín J; LaBranche CC; González-Scarano F
J Virol; 2001 Apr; 75(8):3568-80. PubMed ID: 11264346
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional characterization of the human CCR5 receptor in complex with HIV gp120 envelope glycoprotein and CD4 receptor by molecular modeling studies.
Liu S; Fan S; Sun Z
J Mol Model; 2003 Oct; 9(5):329-36. PubMed ID: 14517611
[TBL] [Abstract][Full Text] [Related]
11. Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta32 heterozygote.
Gorry PR; Dunfee RL; Mefford ME; Kunstman K; Morgan T; Moore JP; Mascola JR; Agopian K; Holm GH; Mehle A; Taylor J; Farzan M; Wang H; Ellery P; Willey SJ; Clapham PR; Wolinsky SM; Crowe SM; Gabuzda D
Virology; 2007 May; 362(1):163-78. PubMed ID: 17239419
[TBL] [Abstract][Full Text] [Related]
12. The role of the N-terminal segment of CCR5 in HIV-1 Env-mediated membrane fusion and the mechanism of virus adaptation to CCR5 lacking this segment.
Melikyan GB; Platt EJ; Kabat D
Retrovirology; 2007 Aug; 4():55. PubMed ID: 17686153
[TBL] [Abstract][Full Text] [Related]
13. A tyrosine-sulfated peptide based on the N terminus of CCR5 interacts with a CD4-enhanced epitope of the HIV-1 gp120 envelope glycoprotein and inhibits HIV-1 entry.
Farzan M; Vasilieva N; Schnitzler CE; Chung S; Robinson J; Gerard NP; Gerard C; Choe H; Sodroski J
J Biol Chem; 2000 Oct; 275(43):33516-21. PubMed ID: 10938094
[TBL] [Abstract][Full Text] [Related]
14. Gp120 V3-dependent impairment of R5 HIV-1 infectivity due to virion-incorporated CCR5.
Monde K; Maeda Y; Tanaka Y; Harada S; Yusa K
J Biol Chem; 2007 Dec; 282(51):36923-32. PubMed ID: 17971448
[TBL] [Abstract][Full Text] [Related]
15. Adaptation of HIV-1 to cells with low expression of the CCR5 coreceptor.
Espy N; Pacheco B; Sodroski J
Virology; 2017 Aug; 508():90-107. PubMed ID: 28521215
[TBL] [Abstract][Full Text] [Related]
16. Highly conserved beta16/beta17 beta-hairpin structure in human immunodeficiency virus type 1 YU2 gp120 is critical for CCR5 binding.
Mechulam A; Cerutti M; Pugnière M; Missé D; Gajardo J; Roquet F; Robinson J; Veas F
J Mol Med (Berl); 2005 Jul; 83(7):542-52. PubMed ID: 15905975
[TBL] [Abstract][Full Text] [Related]
17. CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120.
Wang WK; Dudek T; Zhao YJ; Brumblay HG; Essex M; Lee TH
Proc Natl Acad Sci U S A; 1998 May; 95(10):5740-5. PubMed ID: 9576954
[TBL] [Abstract][Full Text] [Related]
18. Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env protein.
Blanpain C; Doranz BJ; Vakili J; Rucker J; Govaerts C; Baik SS; Lorthioir O; Migeotte I; Libert F; Baleux F; Vassart G; Doms RW; Parmentier M
J Biol Chem; 1999 Dec; 274(49):34719-27. PubMed ID: 10574939
[TBL] [Abstract][Full Text] [Related]
19. Functional mimicry of a human immunodeficiency virus type 1 coreceptor by a neutralizing monoclonal antibody.
Xiang SH; Farzan M; Si Z; Madani N; Wang L; Rosenberg E; Robinson J; Sodroski J
J Virol; 2005 May; 79(10):6068-77. PubMed ID: 15857992
[TBL] [Abstract][Full Text] [Related]
20. Theoretical studies on the interactions and interferences of HIV-1 glycoprotein gp120 and its coreceptor CCR5.
Da LT; Wu YD
J Chem Inf Model; 2011 Feb; 51(2):359-69. PubMed ID: 21284403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
